Related Experiment Videos
Somatostatin receptor scintigraphy: the definitive technique for characterizing vasoactive intestinal
J W Thomason1, R S Martin, M E Fincher
1Department of Medicine, Medical College of Georgia, Augusta, USA. jthomaso@mail.mcg.edu
Clinical Nuclear Medicine
|September 13, 2000
Abstract:
Vasoactive intestinal peptide-secreting tumors (VIPomas) are extremely rare and difficult to diagnose. The authors describe a patient who was found to have a VIPoma after 3 years of symptoms. Somatostatin receptor scintigraphy using indium-labeled octreotide localized her tumor and prompted a surgical resection. This is the preferred imaging study for the earliest, most accurate, and cost-effective identification of VIPomas and their metastases.